Financial comparisons Celltrion, Inc.

Stocks

End-of-day quote Korea S.E. Other stock markets 21/07/2026			5-day change	1st Jan Change
1,71,600.00 ^KRW	-0.58%		-2.00%	-0.45%

14/07	Celltrion Terminates, Withdraws EMA Trial Application for CT-P51 Biosimilar	MT
07/07	Celltrion Submits Amendment for Phase 3 Trial of Cancer Biosimilar to US FDA	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Revenues (Y-1)	Net Margin (Y-1)	EBIT Margin (Y-1)	ROE (Y-1)	ROA (Y-1)	Leverage (Y-1)
CELLTRION, INC.	288.36Cr	24.74%	28.07%	5.94%	4.75%	1.77x
LONZA GROUP AG	823.63Cr	14.53%	21.7%	10.28%	4.9%	1.58x
BEONE MEDICINES AG	534.3Cr	5.37%	8.37%	29.84%	16.27%	-5.99x
IQVIA HOLDINGS INC.	1.63TCr	8.34%	13.38%	32.9%	4.79%	3.63x
ASCENDIS PHARMA A/S	85Cr	-31.67%	-18.92%	-	-	1.57x
MEDPACE HOLDINGS, INC.	253.02Cr	17.83%	20.93%	70.23%	22.13%	-0.89x
EUROFINS SCIENTIFIC SE	856.64Cr	6.51%	14.79%	9.61%	4.34%	2.22x
ICON PUBLIC LIMITED COMPANY	825.13Cr	2.78%	16.66%	10.62%	6.02%	1.8x
ABIVAX	54.01L	-7,306.52%	-5,350%	-135.58%	-	2.1x
BIO-TECHNE CORPORATION	121.96Cr	6.02%	31.45%	15.37%	11.65%	0.43x
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	401.54Cr	-3.59%	19.77%	15.46%	6.99%	1.98x
KYMERA THERAPEUTICS, INC.	3.92Cr	-794.04%	-891.07%	-25.78%	-22.89%	4.75x
TEMPUS AI, INC.	127.18Cr	-19.27%	-3.71%	-38.64%	-6.61%	-65.61x
PROTAGONIST THERAPEUTICS, INC.	4.6Cr	-282.83%	-343.63%	-20.18%	-18.42%	0.82x
IONIS PHARMACEUTICALS, INC.	94Cr	-40.36%	-40.47%	-70.72%	-11.67%	4.51x
PHARMARON BEIJING CO., LTD.	201.52Cr	11.8%	13.68%	11.6%	6.52%	1.83x
ALKERMES PLC	147.59Cr	16.37%	17.21%	14.72%	10.64%	-2.06x
Average	376.46Cr	-492%	-378.93%	-4.02%	2.63%	-2.68x
Weighted average by Cap.	556.57Cr	-323.06%	-242.33%	6.5%	5.33%	-1.13x